Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Halt Medical Introduces Team To Commercialize Acessa™ System For The Treatment Of Uterine Fibroids

LIVERMORE, Calif., Jan. 9, 2013 /PRNewswire/ -- Halt Medical, Inc. introduced today a team to drive commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids.

"It gives me great pleasure to introduce Rodney Marcy as our Senior Vice President of Sales and Marketing," said Jeffrey Cohen, Halt's Chief Executive Officer. "Rodney has extensive commercial experience in the medical device field, and women's health sector. This will be instrumental in our successful launch of Acessa."

Most recently, Mr. Marcy was Vice President of Sales and Marketing for venture-funded Interlace Medical, Inc. (acquired by Hologic, Inc.).  He was also Director of Sales for the launch of the Gynecare Division of ETHICON, Inc., successfully introducing more than five major platform technologies in women's health. He has held senior management positions with Johnson and Johnson and Covidien.

"Acessa is the only medical device that can be used by gynecologists to treat all fibroid symptoms and types," said Mr. Marcy. "It is truly a revolutionary alternative for the millions of women with fibroids who choose to suffer with their symptoms rather than having their uterus removed. Our launch of Acessa will be led by three talented Regional Sales Directors: Larry Anderson, Tyler Holcomb, and Mike Roddick."

Russ DeLonzor, President & COO, added, "We will need to support our customers in the critical areas of reimbursement and professional education. I'm delighted to announce the following additions to the Halt Medical team: Jayne A. Little, Vice President of Global Health Economics and Reimbursement, and Nonni Letasse, R.N., Senior Director of Professional Education and Corporate Compliance."

Ms. Little was, most recently, the Vice President of Reimbursement at Optonol, Inc. (acquired by Alcon, Inc.).  Ms. Little has been responsible for AMA CPT code implementation, Medicare and commercial payer coverage and policy. Joining Ms. Little's team is Sean McKinney, Region Director, Reimbursement and Healthcare Economics.

Ms. Letasse was Senior Director, Global Professional Education for Conceptus, Inc. She has over twenty years of training experience in the women's health sector. She has selected Michelle Schwinges, Professional Education Specialist, to round out her group.

Jeffrey Cohen added, "We now have FDA clearance, the capital, the product, and the team to successfully launch Acessa."

About Halt Medical, Inc.

Founded in 2004, Halt Medical is a medical device company focused on establishing a new standard of care for women with symptomatic uterine fibroids. The Company has developed and launched the Acessa System and Procedure, using radiofrequency energy to destroy uterine fibroids. The results of both U.S. and international trials have led to the clearance of the product by the FDA for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. As well, the System has CE marking in the European Union and is licensed for sale in Canada. The Company is located in Brentwood, CA.  For information about the Acessa System, please visit www.haltmedical.com.

SOURCE Halt Medical, Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
The recent trends like cloud computing, social, mobile and Internet of Things are forcing enterprises to modernize in order to compete in the competitive globalized markets. However, enterprises are approaching newer technologies with a more silo-ed way, gaining only sub optimal benefi...
WaveMaker on Tuesday announced WaveMaker Enterprise, licensed software that enables organizations to run their own end-to-end application platform as a service (aPaaS) for building and running custom apps. WaveMaker Enterprise is a commercially available rapid API app development and d...
The impact of DevOps in the cloud era is potentially profound. DevOps helps businesses deliver new features continuously, reduce cycle time and achieve sustained innovation by applying agile and lean principles to assist all stakeholders in an organization that develop, operate, or ben...
The industry is heated with debates on whether adopting private or public cloud is the smartest, best, cheapest, you name it choice. But this debate is missing the mark. Businesses shouldn’t be discussing public vs. private, but rather how can they make the two work together to their g...
After the transaction closes, Eucalyptus Chief Executive Officer (CEO) Marten Mickos, a respected leader in the cloud industry and a longtime advocate of open source, will join HP as senior vice president and general manager of the Cloud business, reporting to Meg Whitman, chairman, pr...
MapR Technologies, Inc., provider of the top-ranked distribution for Apache™ Hadoop®, announced that Dentsu razorfish, a joint venture between digital agency razorfish and Dentsu, the world’s leading advertisement firm, has deployed the MapR Distribution including Hadoop as the underly...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE